Hormonal tumor mapping for liver metastases of gastroenteropancreatic neuroendocrine neoplasms: a novel therapeutic strategy

被引：0
|
作者：
Aya Maekawa
Atsushi Kudo
Mitsuhiro Kishino
Yoshiki Murase
Shuichi Watanabe
Yoshiya Ishikawa
Hiroki Ueda
Keiichi Akahoshi
Kosuke Ogawa
Hiroaki Ono
Shinji Tanaka
Yuko Kinowaki
Minoru Tanabe
机构：
[1] Tokyo Medical and Dental University,Department of Hepatobiliary and Pancreatic Surgery, Graduate School of Medicine
[2] Tokyo Medical and Dental University,Department of Radiology, Graduate School of Medicine
[3] Tokyo Medical and Dental University,Department of Molecular Oncology, Graduate School of Medicine
[4] Tokyo Medical and Dental University,Department of Human Pathology, Graduate School of Medicine
来源：
Journal of Cancer Research and Clinical Oncology | 2022年 / 148卷
关键词：
Functional GEP-NENs; Neuroendocrine neoplasms; Hormonal heterogeneity; Liver metastases;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：697 / 706
页数：9
相关论文
共 50 条
  • [21] Management of Breast Metastases from Gastroenteropancreatic Neuroendocrine Tumor Origin
    Deneve, Jeremiah L.
    Kvols, Larry
    Bui, Marilyn M.
    Strosberg, Jonathan R.
    Kiluk, John V.
    Laronga, Christine
    Lee, Marie C.
    Khakpour, Nazanin
    PANCREAS, 2013, 42 (02) : 373 - 374
  • [22] Novel Therapeutic Agents for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors
    Pavel, M. E.
    Wiedenmann, B.
    HORMONE AND METABOLIC RESEARCH, 2011, 43 (12) : 844 - 853
  • [23] Therapeutic Strategies for Neuroendocrine Liver Metastases
    Frilling, Andrea
    Clift, Ashley K.
    CANCER, 2015, 121 (08) : 1172 - 1186
  • [24] Current status and therapeutic strategy for gastroenteropancreatic neuroendocrine tumors in Japan
    Ito, Tetsuhide
    ENDOCRINE JOURNAL, 2010, 57 : S280 - S280
  • [25] Surgical strategy for neuroendocrine liver metastases
    Fung, Andrew Kai-Yip
    Chong, Charing Ching-Ning
    SURGICAL PRACTICE, 2019, 23 (02) : 59 - 67
  • [26] Impact of primary tumor resection and metastasectomy among gastroenteropancreatic neuroendocrine tumors with liver metastases only on survival
    Chen, Q.
    Li, K.
    Rhodin, K. E.
    Bartholomew, A. J.
    Lidsky, M. E.
    Wei, Q.
    Cai, J.
    Luo, S.
    Zhao, H.
    JOURNAL OF NEUROENDOCRINOLOGY, 2023, 35 : 69 - 69
  • [27] Our clinical experiences of 6 gastroenteropancreatic neuroendocrine tumor (GEP NETs) patients with recurrent liver metastases
    Nakamura, Shoko
    Tomisato, Kota
    Teramoto, Akira
    Kondo, Akiyuki
    Matsukawa, Shinobu
    Yabutani, Akira
    Iraha, Atsushi
    Kobashikawa, Kasen
    Nakamura, Masamoto
    Nakayoshi, Tomokuni
    Uchima, Nobufumi
    Kinjo, Fukunori
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2014, 29 : 258 - 258
  • [28] Advances in the Diagnosis and Therapeutic Management of Gastroenteropancreatic Neuroendocrine Neoplasms (GEP-NENs)
    Kaliszewski, Krzysztof
    Ludwig, Maksymilian
    Greniuk, Maria
    Mikula, Agnieszka
    Zagorski, Karol
    Rudnicki, Jerzy
    CANCERS, 2022, 14 (08)
  • [29] Therapeutic strategies for gastroenteropancreatic neuroendocrine neoplasms: State-of-the-art and future perspectives
    Merola, Elettra
    Michielan, Andrea
    Rozzanigo, Umberto
    Erini, Marco
    Sferrazza, Sandro
    Marcucci, Stefano
    Sartori, Chiara
    Trentin, Chiara
    de Pretis, Giovanni
    Chierichetti, Franca
    WORLD JOURNAL OF GASTROINTESTINAL SURGERY, 2022, 14 (02): : 78 - 106
  • [30] Resection of primary gastroenteropancreatic neuroendocrine tumors in the presence of irresectable liver metastases
    Wadsworth, Philippa K.
    Jones, Robert P.
    Poston, Graeme J.
    INTERNATIONAL JOURNAL OF ENDOCRINE ONCOLOGY, 2016, 3 (04) : 291 - 297
12345